» Articles » PMID: 32394310

Mitochondrial Bioenergetics, Uncoupling Protein-2 Activity, and Reactive Oxygen Species Production in the Small Intestine of a TNBS-induced Colitis Rat Model

Overview
Publisher Springer
Specialty Biochemistry
Date 2020 May 13
PMID 32394310
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD) is often associated with a decrease in energy-dependent nutrient uptake across the jejunum that serves as the main site for absorption in the small intestine. This association has prompted us to investigate the bioenergetics underlying the alterations in jejunal absorption in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in rats. We have found that mitochondrial oxygen consumption did not change in state 2 and state 3 respirations but showed an increase in state 4 respiration indicating a decrease in the respiratory control ratio of jejunal mitochondria during the peak of inflammation. This decrease in the coupling state was found to be guanosine diphosphate-sensitive, hence, implicating the involvement of uncoupling protein-2 (UCP2). Furthermore, the study has reported that the production of reactive oxygen species (ROS), known to be activators of UCP2, correlated negatively with UCP2 activity. Thus, we suggest that ROS production in the jejunum might be activating UCP2 which has an antioxidant activity, and that uncoupling of the mitochondria decreases the efficiency of energy production, leading to a decrease in energy-dependent nutrient absorption. Hence, this study is the first to account for an involvement of energy production and a role for UCP2 in the absorptive abnormalities of the small intestine in animal models of colitis.

Citing Articles

Berberine attenuates TNBS-induced colitis in mice by improving the intestinal microbiota.

Li C, Yin X, Xie C, Zeng J, Song C, Yang G Front Microbiol. 2024; 15:1463005.

PMID: 39268532 PMC: 11392431. DOI: 10.3389/fmicb.2024.1463005.


The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD.

Astorga J, Gasaly N, Dubois-Camacho K, De la Fuente M, Landskron G, Faber K Front Immunol. 2022; 13:1028953.

PMID: 36466902 PMC: 9716353. DOI: 10.3389/fimmu.2022.1028953.